Enterprise Value to EBITDA Multiple ratio Analysis of Supernus Pharma Inc. - Deep Dive


Latest FY EV to EBITDA
Period Ending - Dec-23

12415.38


Very Poor EV to EBITDA
Period Ending - Dec-22
13.17

Indecisive EV to EBITDA
Growth
94157.35 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23

42.64


Very Poor EV to EBITDA
EV to EBITDA Analysis of Supernus Pharma Inc.
Enterprise Value to EBITDA of Supernus Pharma Inc. with value of 12415.38 implies that the company is overvalued.
EV to EBITDA Ratio of SUPN rose handsomely by 94157.35 % this year.
EV to EBITDA Ratio of SUPN trending up for at least three Years.
EV to EBITDA Ratio with value of 7.28 was lowest in Year Dec-20 in last Five Years.
Latest EV to EBITDA Ratio with value of 12415.38 is Greater than Average EV to EBITDA of 2491.57 in last five years.
Other EV to EBITDA Related Info of SUPN that may interest you.
Supernus Pharma Inc. Overview
CodePricePrevious PricePrice ChangeSector
SUPN27.1226.57 2.07 % Drug Manufacturers-Specialty & Generic
Fundamental AnalysisTechnical Analysis
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued.    more ..
Enterprise Value to EBITDA Multiple Formula
EV to EBITDA Related Ratios
EBITDAMarginEVToRevenuePriceToEarningRatio
Tsr Value Index
Poor Value Stock
FY - Historical Enterprise Value to EBITDA Multiple of Supernus Pharma Inc.
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
EV to EBITDA12415.3813.1712.827.289.199.7213.21
Change94157.35 %2.73 %76.10 %-20.82 %-5.37 %-26.42 %-43.16 %
You are view first 7 Records. Log in to view all 17 in Premium view
FY Chart of Enterprise Value to EBITDA Multiple of Supernus Pharma Inc.


Note : All Data Generated at the End of Trading Hours (EOD Data)